MetLife, Inc. (NYSE:MET) Shares Purchased by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company boosted its stake in MetLife, Inc. (NYSE:METFree Report) by 5.0% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 716,635 shares of the financial services provider’s stock after acquiring an additional 33,898 shares during the period. The Manufacturers Life Insurance Company owned 0.10% of MetLife worth $47,391,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Criterion Capital Advisors LLC purchased a new stake in MetLife in the 4th quarter valued at approximately $26,000. Planned Solutions Inc. purchased a new stake in MetLife in the 4th quarter valued at approximately $28,000. Quintet Private Bank Europe S.A. purchased a new stake in shares of MetLife during the 3rd quarter worth approximately $28,000. Tennessee Valley Asset Management Partners purchased a new stake in shares of MetLife during the 4th quarter worth approximately $34,000. Finally, Headlands Technologies LLC purchased a new stake in shares of MetLife during the 3rd quarter worth approximately $36,000. Hedge funds and other institutional investors own 89.81% of the company’s stock.

Insider Buying and Selling at MetLife

In other MetLife news, insider Ramy Tadros sold 4,026 shares of the company’s stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $71.90, for a total value of $289,469.40. Following the completion of the transaction, the insider now directly owns 146,981 shares of the company’s stock, valued at approximately $10,567,933.90. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In other news, EVP Bill Pappas sold 27,000 shares of the stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $72.27, for a total transaction of $1,951,290.00. Following the transaction, the executive vice president now owns 57,768 shares of the company’s stock, valued at $4,174,893.36. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Ramy Tadros sold 4,026 shares of the stock in a transaction dated Wednesday, March 13th. The stock was sold at an average price of $71.90, for a total transaction of $289,469.40. Following the sale, the insider now owns 146,981 shares in the company, valued at approximately $10,567,933.90. The disclosure for this sale can be found here. 0.31% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

MET has been the topic of several research analyst reports. Wells Fargo & Company decreased their price target on MetLife from $86.00 to $85.00 and set an “overweight” rating on the stock in a research note on Friday, May 10th. Morgan Stanley upped their target price on MetLife from $80.00 to $82.00 and gave the company an “overweight” rating in a research note on Monday, April 15th. Piper Sandler reduced their target price on MetLife from $85.00 to $82.00 and set an “overweight” rating on the stock in a research note on Monday, May 6th. StockNews.com lowered MetLife from a “buy” rating to a “hold” rating in a research note on Saturday, May 11th. Finally, Argus upped their target price on MetLife from $77.00 to $80.00 and gave the company a “buy” rating in a research note on Wednesday, May 22nd. Two research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat.com, MetLife has an average rating of “Moderate Buy” and an average price target of $79.08.

Read Our Latest Stock Report on MetLife

MetLife Stock Up 0.1 %

Shares of MetLife stock opened at $70.36 on Thursday. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.58. The company has a fifty day moving average price of $71.92 and a 200 day moving average price of $69.35. The stock has a market cap of $50.03 billion, a price-to-earnings ratio of 24.18, a price-to-earnings-growth ratio of 0.59 and a beta of 1.12. MetLife, Inc. has a twelve month low of $52.59 and a twelve month high of $74.68.

MetLife (NYSE:METGet Free Report) last posted its quarterly earnings data on Wednesday, May 1st. The financial services provider reported $1.83 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.83. The company had revenue of $17.02 billion during the quarter, compared to analysts’ expectations of $17.73 billion. MetLife had a net margin of 3.50% and a return on equity of 20.39%. The firm’s revenue for the quarter was up 5.5% on a year-over-year basis. During the same period in the prior year, the company posted $1.52 EPS. Equities research analysts forecast that MetLife, Inc. will post 8.62 earnings per share for the current fiscal year.

MetLife announced that its Board of Directors has approved a stock repurchase plan on Wednesday, May 1st that permits the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization permits the financial services provider to reacquire up to 6% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s management believes its shares are undervalued.

MetLife Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 11th. Shareholders of record on Tuesday, May 7th will be given a $0.545 dividend. This is a boost from MetLife’s previous quarterly dividend of $0.52. This represents a $2.18 dividend on an annualized basis and a yield of 3.10%. The ex-dividend date is Monday, May 6th. MetLife’s dividend payout ratio is presently 74.91%.

MetLife Company Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Read More

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.